Bionomics Revenue vs. Price To Sales

BNOEFDelisted Stock  USD 0.01  0.00  0.00%   
Based on Bionomics' profitability indicators, Bionomics Limited may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess Bionomics' ability to earn profits and add value for shareholders.
For Bionomics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Bionomics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Bionomics Limited utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Bionomics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Bionomics Limited over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
Please note, there is a significant difference between Bionomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bionomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bionomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Bionomics Limited Price To Sales vs. Revenue Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Bionomics's current stock value. Our valuation model uses many indicators to compare Bionomics value to that of its competitors to determine the firm's financial worth.
Bionomics Limited is the top company in revenue category among its peers. It also is number one stock in price to sales category among its peers . The ratio of Revenue to Price To Sales for Bionomics Limited is about  31,790 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bionomics' earnings, one of the primary drivers of an investment's value.

Bionomics Revenue vs. Competition

Bionomics Limited is the top company in revenue category among its peers. Market size based on revenue of Biotechnology industry is currently estimated at about 1.82 Million. Bionomics retains roughly 263,634 in revenue claiming about 14% of stocks in Biotechnology industry.

Bionomics Price To Sales vs. Revenue

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Bionomics

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
263.63 K
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

Bionomics

P/S

 = 

MV Per Share

Revenue Per Share

 = 
8.29 X
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.

Bionomics Price To Sales Comparison

Bionomics is currently under evaluation in price to sales category among its peers.

Bionomics Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Bionomics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Bionomics will eventually generate negative long term returns. The profitability progress is the general direction of Bionomics' change in net profit over the period of time. It can combine multiple indicators of Bionomics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Bionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers. Bionomics Limited was incorporated in 1996 and is based in Eastwood, Australia. Bionomics is traded on OTC Exchange in the United States.

Bionomics Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Bionomics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Bionomics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Bionomics' important profitability drivers and their relationship over time.

Use Bionomics in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bionomics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bionomics will appreciate offsetting losses from the drop in the long position's value.

Bionomics Pair Trading

Bionomics Limited Pair Trading Analysis

The ability to find closely correlated positions to Bionomics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bionomics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bionomics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bionomics Limited to buy it.
The correlation of Bionomics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bionomics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bionomics Limited moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bionomics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Bionomics position

In addition to having Bionomics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Apparel Thematic Idea Now

Apparel
Apparel Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Apparel theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Apparel Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Consideration for investing in Bionomics Pink Sheet

If you are still planning to invest in Bionomics Limited check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bionomics' history and understand the potential risks before investing.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation